Terravia Holdings (NASDAQ: TVIA) is one of 52 publicly-traded companies in the “Specialty Chemicals” industry, but how does it weigh in compared to its rivals? We will compare Terravia Holdings to similar businesses based on the strength of its analyst recommendations, valuation, risk, earnings, institutional ownership, dividends and profitability.
Institutional and Insider Ownership
43.4% of Terravia Holdings shares are owned by institutional investors. Comparatively, 69.7% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 10.1% of Terravia Holdings shares are owned by insiders. Comparatively, 7.1% of shares of all “Specialty Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
This is a breakdown of recent ratings for Terravia Holdings and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Terravia Holdings Competitors||164||1022||1275||24||2.47|
Terravia Holdings presently has a consensus price target of $1.50, suggesting a potential upside of 3,659.40%. As a group, “Specialty Chemicals” companies have a potential downside of 3.08%. Given Terravia Holdings’ higher probable upside, analysts clearly believe Terravia Holdings is more favorable than its rivals.
Valuation & Earnings
This table compares Terravia Holdings and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Terravia Holdings Competitors||$1.96 billion||$302.17 million||12.48|
Terravia Holdings’ rivals have higher revenue and earnings than Terravia Holdings. Terravia Holdings is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This table compares Terravia Holdings and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Terravia Holdings Competitors||-2.55%||9.11%||3.87%|
Risk & Volatility
Terravia Holdings has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Terravia Holdings’ rivals have a beta of 1.59, meaning that their average stock price is 59% more volatile than the S&P 500.
Terravia Holdings rivals beat Terravia Holdings on 9 of the 11 factors compared.
Terravia Holdings Company Profile
Solazyme, Inc. creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora S.A. and its affiliates, QVC, Inc., SpaceNK Limited, select Nordstrom stores and ULTA Beauty. It offers intermediates/ingredients, such as Tailored oils, powdered oils, and other closely related products targeted at customers in the industrial products, food products and personal care products markets. The Company’s commercial focus is to sell oils, encapsulated oils and whole algal powdered products to companies that use them as intermediates and ingredients.
What are top analysts saying about Terravia Holdings? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Terravia Holdings and related companies.